-
CCK-8, Endogenous Opioids, and Withdrawal Anxiety
2026-08-16
Wen et al. showed that cholecystokinin octapeptide (CCK-8) reduces anxiety-like behavior in morphine-withdrawal rats through CCK1 receptor signaling and endogenous opioid involvement. The pharmacological design separates CCK1-dependent modulation from μ-opioid receptor-dependent effects, offering a mechanistic framework for opioid addiction and withdrawal studies.
-
Nonselective β-Blockers and HCT Engraftment
2026-08-15
The reference study shows that nonselective β-adrenergic receptor inhibitors can impair hematopoietic regeneration after allogeneic hematopoietic cell transplantation, whereas β1-selective inhibition had little comparable effect. By integrating mouse transplantation models with human clinical cohorts, the work identifies β-blocker selectivity, transplant type, posttransplant chemotherapy, and graft size as important determinants of engraftment risk.
-
Protease Inhibition as a Translational Strategy
2026-08-14
Proteases are not simply degradative enzymes; they are context-dependent regulators of signaling, cell death, proteostasis, and disease progression. This article examines how broad chemical perturbation can connect protease activity modulation with translational hypotheses, using the PSMD14–CARM1–FERMT1 axis in hepatocellular carcinoma as a mechanistic anchor. It also provides practical guidance for deploying the DiscoveryProbe™ Protease Inhibitor Library in biochemical, cellular, and high-content workflows while distinguishing exploratory evidence from disease-relevant validation.
-
Naloxone Hydrochloride as Translational Leverage
2026-08-14
A thought-leadership guide to using Naloxone hydrochloride as a mechanistic probe across opioid receptor signaling, neural stem cell biology, immune modulation, and behavioral research, with practical workflow guidance and translational strategy.
-
METTL16–SENP3–LTF Axis in HCC Ferroptosis
2026-08-13
Wang et al. identify a METTL16–SENP3–LTF regulatory axis that protects hepatocellular carcinoma cells from ferroptosis by controlling labile iron availability. The study combines molecular assays, organoids, xenografts, genetically engineered mice, and human samples to connect m6A-dependent RNA regulation with iron metabolism and tumor progression.
-
ER-Targeting Peptide Self-Assembly in Cancer Cells
2026-08-13
The reference study develops an alkaline-phosphatase-triggered peptide that self-assembles at the endoplasmic reticulum through a p-toluenesulfonamide targeting group. This design selectively increases ER stress and cancer-cell death while reducing the concentration dependence of earlier intracellular enzyme-instructed self-assembly strategies.
-
Glutathione Redox Logic in Hypoxic Tumors
2026-08-12
Hypoxia and immunometabolic competition can reshape tumor redox biology, but translational interpretation depends on measuring reduced and oxidized glutathione together. This thought-leadership guide connects mechanistic insight with a practical validation strategy using the GSH and GSSG Assay Kit.
-
Neomycin sulfate for RNA/DNA Assays
2026-08-12
Neomycin sulfate is more than an antimicrobial: its structure-selective effects support ribozyme, TAR, DNA-triplex, and ryanodine receptor assays. This workflow-led guide shows how to prepare aqueous stocks, separate genuine binding from ionic confounding, and use a rat allergic-rhinitis study as a careful model for multi-endpoint experimental design.
-
Biotin-16-UTP RNA Labeling Workflow
2026-08-11
Biotin-16-UTP provides a biotin-labeled uridine triphosphate for generating affinity-tagged RNA during in vitro transcription, supporting RNA detection and purification and downstream binding assays. It is intended for controlled research workflows only, not diagnostic or medical use, and requires cold storage and empirical optimization for each polymerase and RNA template.
-
AhR–RBX1/HSF1 Signaling in Acute Pancreatitis
2026-08-11
A 2025 study identifies an AhR–RBX1/HSF1 regulatory axis that links macrophage behavior, pancreatic acinar-cell stress, and tight-junction preservation during severe acute pancreatitis. Its combination of mouse modeling, primary-cell experiments, protein-interaction analysis, and pharmacological perturbation provides a mechanistic framework for studying epithelial barrier injury, while also highlighting unresolved questions about HSF1 regulation.
-
Olaparib: From PARP Trapping to Nascent-Strand Repair
2026-08-10
Olaparib and AZD2281 are examined through a replication-focused lens, connecting PARP trapping with BRCA2-dependent nascent-strand maturation. Learn how this 2026 finding can improve DNA damage response assay design, BRCA-associated cancer research, and radiosensitization studies.
-
DOTAP for Nucleic Acid Delivery and Immune Assays
2026-08-09
DOTAP combines electrostatic nucleic acid binding with adaptable liposomal delivery, making it useful for transient gene expression, functional genomics, and formulation screening. This workflow-focused guide shows how to apply it to immune-metabolism assays inspired by recent nano-zoledronate research while separating established product behavior from exploratory hypotheses.
-
BFH772 (VEGFR2 inhibitor): Lab Guide
2026-08-08
BFH772 is a selective small-molecule VEGFR2 inhibitor for controlled studies of VEGFR2-mediated signaling and angiogenesis, including biochemical, cellular, and tumor-model workflows. It is suited to organic-solvent formulations and selectivity-focused experiments, but should not be used when a water-soluble compound, broad kinase inhibition, or an established clinical dosing protocol is required.
-
Isradipine (Dynacirc): L-Type Assay Logic
2026-08-07
Isradipine (Dynacirc) is examined here as an L-type calcium-channel probe rather than simply an antihypertensive compound. Learn how to interpret its vascular and neuronal effects alongside the subtype-selectivity findings of Sidach and Mintz.
-
DiscoveryProbe Protease Inhibitor Library: Translational Wor
2026-08-07
Harness the DiscoveryProbe Protease Inhibitor Library for robust, high throughput screening in apoptosis, cancer, and infectious disease research. This guide demystifies experimental setup, workflow optimization, and troubleshooting, directly linking the library’s capabilities to cutting-edge translational applications.